FDA District Office meeting
This article was originally published in The Gray Sheet
Scheduled for July 17 in New Orleans to discuss "good clinical practices in investigational product research." Topics to be discussed are requirements for conducting investigational research and "practical issues," including how to prepare for a data audit and what to expect during an investigation. The meeting is formatted for open dialogue between FDA and individuals involved in investigational product research. First priority for attendance will be given to individuals located in Louisiana and Mississippi. Call Rebecca Asente at 504/589-6344, ext. 158, for additional information...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.